Kreston Global announces new life sciences and healthcare sector chairs 

April 26, 2022

Sector: Life Sciences & Healthcare

LONDON – Kreston Global has appointed Sue Staunton and Scott Miles co-chairs of its new Life Sciences and Healthcare sector group. 

The group has formed in recognition of the substantial life sciences and healthcare work carried out by Kreston firms internationally, providing a wealth of expertise to privately owned businesses and investors looking to invest and raise capital in this rapidly growing sector.

Sue Staunton is a joint managing partner of James Cowper Kreston, and Scott Miles is a corporate partner in Kreston Reeves, both UK accounting firms and members of the Kreston Global network. They will be leading an international group of sector experts from Switzerland, India, Singapore, the US, UK and Germany. 

Sue qualified as a chartered accountant with a UK top six firm and held various positions within that business, culminating as National Client Service Director of their technology team, which she co-founded, before leaving to join James Cowper Kreston which has a strong Technology and Life Science cross-disciplinary specialist team which she led for many years.  She provides support for Life Science businesses at all stages of their development from start-up to IPO and has significant experience in working with Government funded bodies operating within the sector such as the Vaccine Manufacturing and Innovation Centre and the Rosalind Franklin Institute as well as VC backed private companies- including a number associated with vaccine development.

Scott is the Life Science Lead Partner at Kreston Reeves, where he has developed a specialist team (supported by David Rosevear) to deliver expert services to the Life Science and Healthcare sectors. He and the team have developed significant relationships with Venture Capital organisations, Family offices, Government organisations and High Net Worth Individuals. 

Scott provides support to start ups with seed funding through to Series A & B raises and onto listings. He was involved with one of the largest Life Science listings in 2021 with 10 entities being rolled up and listed. He also acted for one of the UK’s largest growing Healthcare providers and supported them with a partial exit in 2021. 

2021 saw the Kreston Global network celebrating its 50th anniversary as well as undergoing its own rebrand. 

Sue Staunton said:

“Kreston Global has long had an excellent profile in the Life Sciences space and with this focussed sector group we will be able to take our offering to the next level. This is an exciting time for the Life Sciences and Healthcare sector, and Kreston Global’s dynamism makes us a natural partner for clients in the space. I look forward to working with Scott to harness the strength of our global network.”

Scott Miles said: 

“Kreston Global’s experience in the sector, and forward-looking ethos, mean that we are superbly well placed to offer a unique global offering to clients in the Life Sciences and Healthcare sector. I look forward to working with Sue and the other members of the group to develop our existing practice and support clients on their journeys.”

Liza Robbins, Chief Executive of Kreston Global, said: 

“Sue and Scott have a wealth of experience in the sector and have already done much to develop Kreston Global’s offering. The establishment of a sector group is the natural next step to ensure that we are reaching the right audiences and offering the right services. I would like to congratulate them on their appointments and wish them well as they harness the potential of the network in this exciting area.”